G1 Therapeutics to Participate in BTIG Targeted Therapeutics Conference on February 24, 2020

RESEARCH TRIANGLE PARK, N.C., Feb. 18, 2020 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today announced that Chief Medical Officer Raj Malik, M.D., will participate in the “Breast Cancer – The Moving Landscape” panel discussion at the BTIG Targeted Therapeutics Conference. The conference will take place on Monday, February 24, 2020 at the St.